Loading…

Emerging role of bevacizumab in management of patients with symptomatic hepatic involvement in Hereditary Hemorrhagic Telangiectasia

Saved in:

Bibliographic Details
Published in:	American journal of hematology 2017-11, Vol.92 (11), p.E641-E644
Main Authors:	Chavan, Ajay, Schumann‐Binarsch, Silke, Schmuck, Bernhard, Oltmer, Franziska, Geisthoff, Urban, Hoppe, Florian, Wirsching, Kornelia, Klempnauer, Juergen, Manns, Michael, Philip Thomas, Rohit, Köhne, Claus‐Henning
Format:	Article
Language:	English
Subjects:	Adult Aged Bevacizumab Bevacizumab - administration & dosage Bevacizumab - adverse effects Female Follow-Up Studies Hemorrhage Hereditary hemorrhagic telangiectasia Humans Immunotherapy Liver Liver - metabolism Liver - physiopathology Liver Diseases - blood Liver Diseases - complications Liver Diseases - drug therapy Liver Diseases - physiopathology Male Middle Aged Monoclonal antibodies Off-Label Use Prospective Studies Telangiectasia, Hereditary Hemorrhagic - blood Telangiectasia, Hereditary Hemorrhagic - complications Telangiectasia, Hereditary Hemorrhagic - drug therapy Telangiectasia, Hereditary Hemorrhagic - physiopathology
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!